Doctors

Director of Liver Surgery, Chief Physician, Professor, and Doctoral Supervisor. Specializes in the treatment of benign and malignant liver tumors, gallbladder tumors, and biliary obstruction diseases through robotic and minimally invasive surgery, as well as comprehensive therapeutic approaches, with the implementation of living-donor liver transplantation. Dr. Du graduated from Peking Union Medical College in 2002 with a Ph.D. and joined the Department of Surgery at Peking Union Medical College Hospital. He has been engaged in liver surgery since 2006 and obtained the qualification of Chief Physician from the National Health and Family Planning Commission in 2015. He completed three-month visiting fellowships at the University of Chicago Medicine in 2011, and at Brigham and Women's Hospital and Memorial Sloan Kettering Cancer Center in 2017. Clinically, he excels in the open and laparoscopic diagnosis and treatment of benign and malignant liver tumors, gallbladder tumors, and biliary obstructive diseases. In research, he has received multiple grants including the National Natural Science Foundation, Peking Union Medical College Hospital Youth Fund, and the CAMS Innovation Fund for Medical Sciences. He led the development of a cutting-edge 3D liver function assessment system and holds two patents. He has published over 20 articles in domestic and international medical journals and serves on the editorial boards of several domestic journals.

Director of the General Surgery Teaching and Research Section, Chief Physician, Professor, and Doctoral Supervisor. He specializes in the surgical diagnosis and treatment of pancreatic, gastrointestinal, biliary, and thyroid diseases, with a particular focus on pancreatic diseases. Dr. Zhang received his doctorate in surgery from Peking Union Medical College in 1995. He was a visiting scholar at the Starzl Transplantation Institute at the University of Pittsburgh in April 2002, and conducted postdoctoral research at the Gene Therapy Center at the University of North Carolina from May 2002 to December 2004. He has long been engaged in clinical and basic research in pancreatic surgery, receiving numerous national grants. He also serves as Deputy Editor-in-Chief and editorial board member for multiple prominent Chinese medical journals.

Director of Infectious Diseases, Professor, Chief Physician, and Doctoral Supervisor. Specializes in the diagnosis and treatment of fever of unknown origin and various infectious diseases. Dr. Li has long been committed to the clinical diagnosis, treatment, and basic immunological research of infectious diseases. Over the past 30 years, with the support of major national infectious disease projects, he has made significant contributions to the clinical diagnosis, treatment, and immunological research of HIV/AIDS in China. In 1998, he was the first in the world to discover that antiviral therapy could reconstruct the CD4+ T cell function of AIDS patients, laying an important foundation for the theory of AIDS immune reconstruction. Based on this, he pioneered a comprehensive diagnosis, treatment, and full-process management model for HIV/AIDS antiviral therapy suitable for China's national conditions, forming the 'Chinese Plan' for AIDS antiviral therapy and immune reconstruction, which has been promoted and applied in China and developing countries. This fundamentally changed the low level of clinical treatment for AIDS in China and achieved a series of innovative results domestically and internationally, which were selected as one of the 'Top Ten Scientific and Technological Achievements' in the 60 years since the establishment of the Chinese Academy of Medical Sciences. During the COVID-19 pandemic, he served as an expert in the national medical treatment group for COVID-19, captain of the second batch of medical teams from Peking Union Medical College Hospital sent to Hubei, and head of the hospital's epidemic supervision group. He led nearly 30 experts in the hospital to discuss and formulate the 'Peking Union Medical College Hospital Diagnosis and Treatment Proposal for Novel Coronavirus Pneumonia (V2.0)', which was highly praised by the industry and promoted internationally. During his frontline anti-epidemic work in Wuhan, he discovered and proposed the immune pathogenesis of COVID-19 and its three-stage disease course. He also discovered the hypercoagulable and over-immune activation state of COVID-19 patients and proposed an effective solution of intravenous immunoglobulin combined with low molecular weight heparin, reducing the mortality rate of severe and critically ill patients. He stayed in Wuhan for 81 days until local COVID-19 cases were cleared.

Assistant Director of the Psychological Medicine Department, Associate Chief Physician, and Associate Professor. Dr. Li holds an MD and graduated from Peking Union Medical College in 2007. He specializes in the pharmacological and psychological treatment of common psychiatric and psychological disorders in general hospitals, including functional somatic symptoms, anxiety disorders, and depression.

Deputy Director of the Department of Stomatology, Chief Physician, Professor, and Doctoral Supervisor. Dr. Tao Zhang specializes in the diagnosis and treatment of oral and maxillofacial and head and neck tumors, plastic surgery for facial and cervical defects and deformities, microsurgical reconstruction, and oral and maxillofacial injuries. In 2010, he worked as a Surgical Fellow at the University of Maryland Medical Center in the Department of Oral and Maxillofacial Surgery for one year, focusing on maxillofacial tumors and microsurgical reconstruction of head and neck defects. In 2011, as a state-sponsored visiting scholar, he conducted clinical research in head and neck and plastic surgery at MD Anderson Cancer Center, Harvard Medical School, and Queen Mary Hospital of the University of Hong Kong. He has also served as the principal investigator for multiple national, Beijing municipal, and ministerial-level research projects.

Attending Physician. Specializes in the diagnosis and treatment of various rheumatic and immune diseases, including systemic lupus erythematosus, lupus nephritis, Sjögren's syndrome, psoriatic arthritis, gout, rheumatoid arthritis, spondyloarthropathy, and systemic vasculitis. Dr. Bai graduated from the 8-year clinical medicine program at Tsinghua University Peking Union Medical College in 2011, obtaining his Medical Doctorate (MD). He has worked in the Department of Internal Medicine at Peking Union Medical College Hospital since 2011, serving as a Resident Physician, Chief Resident, and currently as an Attending Physician in the Department of Rheumatology. In 2014, he participated in an exchange study program at the University of California, San Francisco (UCSF). He has received the Outstanding Resident Award and has published multiple articles as the first or corresponding author in SCI and Chinese core journals, in addition to co-authoring several professional books.

Deputy Director of the Clinical Nutrition Department, Chief Physician, Doctoral Supervisor, and Professor. He is responsible for clinical nutrition diagnosis and treatment as well as department management. He specializes in the management of malnutrition due to various diseases such as tumors, anorexia nervosa, and intestinal failure. He also specializes in nutritional intervention for geriatric malnutrition and sarcopenia, medical nutritional weight loss, and family parenteral and enteral nutrition.

Director of the Otolaryngology (ENT) Department, Chief Physician, Doctoral Supervisor, and Professor. Specializes in the endoscopic surgical treatment and basic research of sinonasal inflammatory diseases and tumors, as well as the basic and clinical research of endoscopic minimally invasive surgery.

Assistant Director of Infectious Diseases Department, Chief Physician, Master's Supervisor, and Professor. Specializes in the diagnosis and treatment of AIDS, fever of unknown origin, bloodstream infections, tuberculosis, hepatitis, and other difficult and severe infections (including bacterial, fungal, viral, and CNS infections). Serves as the leader of the HIV Infection MDT Consultation Group and is a member of the Shingles Multidisciplinary Full-Course Management Team. Graduated with an MD in Clinical Medicine from Peking Union Medical College in 1998. Conducted postdoctoral studies and worked as a visiting scholar at Pierre and Marie Curie University (Paris VI) in France and McGill University in Canada. Has undertaken major national infectious disease projects, with research focusing on the pathological mechanisms of immunodeficiency diseases, multi-organ complications of AIDS, and changes in intestinal flora.

Chief Physician, Professor, and Master's Supervisor in the Department of Hematology. She specializes in various hematological disorders, lymphoma, and both autologous and allogeneic hematopoietic stem cell transplantation. Dr. Zhang graduated with a degree in Clinical Medicine from Sun Yat-sen University of Medical Sciences in 1995 and joined the Department of Internal Medicine at Peking Union Medical College Hospital in August of the same year. She obtained her Master's degree from Peking Union Medical College in 2002.

Director of Endocrinology, Professor, Chief Physician, and Doctoral Supervisor at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Dr. Xia specializes in endocrine and metabolic disorders, with profound expertise in the basic and clinical research of metabolic bone diseases. He has rich clinical experience in diagnosing and treating common endocrine and metabolic diseases such as diabetes, hyperthyroidism, metabolic syndrome, hypothalamic-pituitary diseases, adrenal diseases, and gonadal diseases. He served as a visiting scholar at the University of Tokyo, Japan, from 2000 to 2001. His current research focuses on the genetic pathogenesis of endocrine and metabolic diseases, the epidemiology of osteoporosis and fractures, and basic and clinical research on rickets and osteomalacia. He has led multiple national research projects, including those funded by the National Natural Science Foundation of China, and has published over 80 scientific papers. He also serves as an editorial board member and editorial director for the 'Chinese Journal of Osteoporosis and Bone Mineral Research'.

Professor Weigang Yan is the Deputy Director of Urology, Chief Physician, Professor, and Doctoral Supervisor at Peking Union Medical College Hospital. He specializes in the diagnosis and treatment of various urinary diseases, especially prostate cancer, adrenal disease, and kidney cancer. He is highly skilled in urological robot-assisted surgery, laparoscopic surgery, and various minimally invasive surgeries. His research focuses on urological tumors and minimally invasive urology, with an emphasis on prostate cancer, kidney cancer, and adrenal tumors.